 Curtis VandenBerg
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anterior Cruciate Ligament Injuries | 8 | 2023 | 131 | 2.510 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 9 | 2023 | 116 | 2.200 |
Why?
| | Femoral Fractures | 2 | 2022 | 67 | 1.390 |
Why?
| | Hip Joint | 2 | 2019 | 131 | 1.130 |
Why?
| | Bone Cysts | 1 | 2022 | 11 | 0.810 |
Why?
| | Fractures, Spontaneous | 1 | 2022 | 14 | 0.810 |
Why?
| | Hamstring Tendons | 1 | 2021 | 7 | 0.770 |
Why?
| | Fracture Fixation, Internal | 2 | 2022 | 196 | 0.750 |
Why?
| | Closed Fracture Reduction | 1 | 2019 | 6 | 0.690 |
Why?
| | Bone Neoplasms | 1 | 2022 | 194 | 0.690 |
Why?
| | Therapeutic Irrigation | 1 | 2019 | 67 | 0.670 |
Why?
| | Debridement | 1 | 2019 | 75 | 0.660 |
Why?
| | Fracture Fixation, Intramedullary | 2 | 2020 | 56 | 0.650 |
Why?
| | Arthritis, Infectious | 1 | 2019 | 50 | 0.650 |
Why?
| | Fractures, Closed | 1 | 2019 | 15 | 0.640 |
Why?
| | Tibial Fractures | 1 | 2019 | 70 | 0.640 |
Why?
| | Clinical Protocols | 2 | 2020 | 234 | 0.600 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 96 | 0.580 |
Why?
| | Spine | 1 | 2018 | 141 | 0.550 |
Why?
| | Femoracetabular Impingement | 1 | 2016 | 36 | 0.540 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 250 | 0.510 |
Why?
| | Pubic Bone | 1 | 2014 | 4 | 0.490 |
Why?
| | Patient Compliance | 1 | 2018 | 524 | 0.460 |
Why?
| | Knee Joint | 5 | 2023 | 325 | 0.430 |
Why?
| | Child | 16 | 2023 | 18489 | 0.410 |
Why?
| | Lower Extremity | 4 | 2023 | 337 | 0.410 |
Why?
| | Anterior Cruciate Ligament | 3 | 2023 | 79 | 0.410 |
Why?
| | Retrospective Studies | 13 | 2022 | 12608 | 0.410 |
Why?
| | Range of Motion, Articular | 5 | 2021 | 354 | 0.380 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1180 | 0.380 |
Why?
| | Biomechanical Phenomena | 5 | 2021 | 677 | 0.380 |
Why?
| | Tendons | 3 | 2022 | 120 | 0.370 |
Why?
| | Patellar Ligament | 2 | 2022 | 22 | 0.360 |
Why?
| | Athletes | 4 | 2023 | 323 | 0.340 |
Why?
| | Adolescent | 15 | 2023 | 17890 | 0.330 |
Why?
| | Tibial Meniscus Injuries | 2 | 2019 | 43 | 0.320 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1483 | 0.320 |
Why?
| | Menisci, Tibial | 2 | 2019 | 53 | 0.320 |
Why?
| | Reoperation | 2 | 2022 | 525 | 0.310 |
Why?
| | Exercise Test | 3 | 2020 | 539 | 0.290 |
Why?
| | Female | 20 | 2023 | 59913 | 0.290 |
Why?
| | Orthopedic Procedures | 2 | 2018 | 213 | 0.260 |
Why?
| | Child, Preschool | 5 | 2022 | 9133 | 0.240 |
Why?
| | Length of Stay | 2 | 2019 | 958 | 0.240 |
Why?
| | Male | 17 | 2023 | 55949 | 0.240 |
Why?
| | Return to Sport | 3 | 2023 | 78 | 0.240 |
Why?
| | Databases, Factual | 2 | 2019 | 1138 | 0.240 |
Why?
| | Autografts | 2 | 2021 | 41 | 0.230 |
Why?
| | Humans | 24 | 2023 | 115589 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2019 | 291 | 0.230 |
Why?
| | Movement | 3 | 2021 | 246 | 0.230 |
Why?
| | United States | 4 | 2019 | 12295 | 0.210 |
Why?
| | Patellofemoral Joint | 1 | 2022 | 9 | 0.210 |
Why?
| | Knee Injuries | 2 | 2019 | 89 | 0.190 |
Why?
| | Femur | 1 | 2022 | 194 | 0.180 |
Why?
| | Rotation | 2 | 2021 | 113 | 0.180 |
Why?
| | Salter-Harris Fractures | 1 | 2020 | 11 | 0.180 |
Why?
| | Humeral Fractures | 1 | 2020 | 50 | 0.170 |
Why?
| | Data Collection | 2 | 2019 | 636 | 0.170 |
Why?
| | Ankle Injuries | 1 | 2020 | 74 | 0.160 |
Why?
| | Conversion Disorder | 1 | 2019 | 9 | 0.160 |
Why?
| | Casts, Surgical | 1 | 2019 | 31 | 0.160 |
Why?
| | Bone Nails | 1 | 2019 | 62 | 0.160 |
Why?
| | Treatment Outcome | 3 | 2022 | 9159 | 0.160 |
Why?
| | Hospitals, Teaching | 1 | 2019 | 103 | 0.160 |
Why?
| | Shoulder Dislocation | 1 | 2019 | 48 | 0.150 |
Why?
| | Hospital Costs | 1 | 2019 | 105 | 0.150 |
Why?
| | Upper Extremity | 1 | 2019 | 84 | 0.150 |
Why?
| | Sports | 1 | 2020 | 175 | 0.150 |
Why?
| | Insurance Coverage | 1 | 2019 | 204 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2019 | 147 | 0.150 |
Why?
| | Social Class | 1 | 2019 | 210 | 0.150 |
Why?
| | Risk Management | 1 | 2018 | 89 | 0.140 |
Why?
| | Blood Coagulation Disorders | 1 | 2019 | 196 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2020 | 2161 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3071 | 0.130 |
Why?
| | Risk Factors | 3 | 2018 | 8697 | 0.130 |
Why?
| | Inpatients | 1 | 2019 | 380 | 0.130 |
Why?
| | Interleukin-1alpha | 1 | 2015 | 55 | 0.130 |
Why?
| | Odds Ratio | 1 | 2018 | 962 | 0.130 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2014 | 20 | 0.120 |
Why?
| | Comorbidity | 1 | 2019 | 1473 | 0.120 |
Why?
| | Tissue Engineering | 2 | 2015 | 366 | 0.120 |
Why?
| | Athletic Injuries | 1 | 2020 | 456 | 0.120 |
Why?
| | Chondrogenesis | 1 | 2014 | 79 | 0.110 |
Why?
| | Cytokines | 2 | 2015 | 1853 | 0.110 |
Why?
| | Chondrocytes | 1 | 2015 | 199 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2018 | 3022 | 0.110 |
Why?
| | Young Adult | 2 | 2019 | 10470 | 0.100 |
Why?
| | Pelvic Bones | 1 | 2014 | 128 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2335 | 0.100 |
Why?
| | Infant | 2 | 2022 | 7979 | 0.100 |
Why?
| | Prospective Studies | 3 | 2020 | 6264 | 0.090 |
Why?
| | Hospitalization | 1 | 2019 | 1765 | 0.090 |
Why?
| | Quality Improvement | 1 | 2018 | 958 | 0.090 |
Why?
| | Plyometric Exercise | 2 | 2018 | 4 | 0.080 |
Why?
| | Laryngectomy | 1 | 2007 | 14 | 0.070 |
Why?
| | Salvage Therapy | 1 | 2007 | 128 | 0.070 |
Why?
| | Kinetics | 2 | 2020 | 1569 | 0.070 |
Why?
| | Surgical Flaps | 1 | 2007 | 121 | 0.070 |
Why?
| | Molybdenum | 1 | 2005 | 8 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2392 | 0.060 |
Why?
| | Tumor Burden | 1 | 2005 | 261 | 0.060 |
Why?
| | Angiogenesis Inhibitors | 1 | 2005 | 216 | 0.050 |
Why?
| | Cattle | 2 | 2015 | 935 | 0.050 |
Why?
| | Patella | 1 | 2022 | 25 | 0.050 |
Why?
| | Ligaments, Articular | 1 | 2022 | 56 | 0.050 |
Why?
| | Cohort Studies | 2 | 2023 | 4944 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2023 | 195 | 0.050 |
Why?
| | Cadaver | 1 | 2022 | 316 | 0.050 |
Why?
| | Head and Neck Neoplasms | 1 | 2005 | 425 | 0.050 |
Why?
| | Humerus | 1 | 2020 | 43 | 0.040 |
Why?
| | Open Fracture Reduction | 1 | 2020 | 24 | 0.040 |
Why?
| | Pain Management | 1 | 2023 | 291 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 577 | 0.040 |
Why?
| | Los Angeles | 1 | 2019 | 56 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2019 | 1718 | 0.040 |
Why?
| | Lacerations | 1 | 2019 | 30 | 0.040 |
Why?
| | Rupture | 1 | 2019 | 95 | 0.040 |
Why?
| | Posture | 1 | 2020 | 150 | 0.040 |
Why?
| | Bone Screws | 1 | 2020 | 124 | 0.040 |
Why?
| | Time and Motion Studies | 1 | 2018 | 21 | 0.040 |
Why?
| | Hip | 1 | 2018 | 46 | 0.040 |
Why?
| | Knee | 1 | 2018 | 50 | 0.040 |
Why?
| | Ankle | 1 | 2018 | 71 | 0.040 |
Why?
| | Patients | 1 | 2019 | 164 | 0.040 |
Why?
| | Arthroscopy | 1 | 2019 | 200 | 0.040 |
Why?
| | Pain | 1 | 2023 | 712 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2015 | 3914 | 0.040 |
Why?
| | Joint Instability | 1 | 2019 | 166 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 160 | 0.040 |
Why?
| | Pain Measurement | 1 | 2019 | 449 | 0.030 |
Why?
| | Quality of Life | 2 | 2023 | 2385 | 0.030 |
Why?
| | Child Health Services | 1 | 2019 | 178 | 0.030 |
Why?
| | Cell Movement | 2 | 2014 | 867 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 952 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 2018 | 269 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 783 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 478 | 0.030 |
Why?
| | Adult | 1 | 2016 | 30719 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2018 | 4440 | 0.030 |
Why?
| | Dogs | 1 | 2015 | 341 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1357 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 263 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2264 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4435 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1490 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2015 | 3580 | 0.020 |
Why?
| | Pharyngeal Diseases | 1 | 2007 | 12 | 0.020 |
Why?
| | Cutaneous Fistula | 1 | 2007 | 13 | 0.020 |
Why?
| | Laryngeal Neoplasms | 1 | 2007 | 27 | 0.020 |
Why?
| | Fistula | 1 | 2007 | 27 | 0.020 |
Why?
| | Deglutition | 1 | 2007 | 58 | 0.020 |
Why?
| | Animals | 3 | 2015 | 32102 | 0.020 |
Why?
| | Middle Aged | 2 | 2023 | 26998 | 0.020 |
Why?
| | Speech | 1 | 2007 | 68 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2007 | 210 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2005 | 183 | 0.010 |
Why?
| | Mice, SCID | 1 | 2005 | 321 | 0.010 |
Why?
| | Probability | 1 | 2005 | 294 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 552 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 850 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 283 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1044 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 795 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1642 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2262 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 695 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2005 | 1048 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5034 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 2987 | 0.010 |
Why?
| | Mice | 1 | 2005 | 15052 | 0.000 |
Why?
|
|
VandenBerg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|